Global POC Haematology Diagnostics Market 2024-2028

The POC haematology diagnostics market is forecasted to grow by USD 7.15 bn during 2023-2028, accelerating at a CAGR of 10.33% during the forecast period. The report on the POC haematology diagnostics market provides a holistic analysis, market size and forecast, trends, growth drivers, and challenges, as well as vendor analysis covering around 25 vendors.

The report offers an up-to-date analysis regarding the current market scenario, the latest trends and drivers, and the overall market environment. The market is driven by the increasing prevalence of blood disorders and infectious diseases, increasing growth in POC hematology diagnostics product launches, and the paradigm shift from benchtop to portable hematology diagnostic systems.

Market Scope
Base Year	2023
End Year	2028
Series Year	2024-2028
Growth Momentum	Accelerate
YOY 2024	9.65%
CAGR	10.33%
Incremental Value	$7.15bn

Technavio's POC haematology diagnostics market is segmented as below:

By End-user

Hospitals and clinics
Homecare settings
Clinical diagnostic laboratories

By Product

Consumables
Systems

By Geographical Landscape

North America
Europe
Asia
Rest of World (ROW)

This study identifies the increase in online marketing as one of the prime reasons driving the POC haematology diagnostics market growth during the next few years. Also, increase in the number of OEMs and increase in adoption of next-generation hematology diagnostic products will lead to sizable demand in the market.

The report on the POC haematology diagnostics market covers the following areas:

POC haematology diagnostics market sizing
POC haematology diagnostics market forecast
POC haematology diagnostics market industry analysis

The robust vendor analysis is designed to help clients improve their market position, and in line with this, this report provides a detailed analysis of several leading POC haematology diagnostics market vendors that include A. Menarini Industrie Farmaceutiche Riunite Srl, Abbott Laboratories, Chengdu Seamaty Technology Co. Ltd., Danaher Corp., DIAGON Kft., Diamond Diagnostics Inc., Drucker Diagnostics LLC, EKF Diagnostics Holdings Plc, F. Hoffmann La Roche Ltd., HORIBA Ltd., Medsource Ozone Biomedicals Pvt. Ltd., Norma Instruments Zrt., Nova Biomedical Corp., PixCell Medical Technologies Ltd., S.D. Sight Diagnostics Ltd., Sekisui Diagnostics LLC, Mindray Bio medical Electronics Co. Ltd., Siemens AG, Sysmex Corp., and Transasia Bio Medicals Ltd.. Also, the POC haematology diagnostics market analysis report includes information on upcoming trends and challenges that will influence market growth. This is to help companies strategize and leverage all forthcoming growth opportunities.

The study was conducted using an objective combination of primary and secondary information including inputs from key participants in the industry. The report contains a comprehensive market and vendor landscape in addition to an analysis of the key vendors.

The publisher presents a detailed picture of the market by the way of study, synthesis, and summation of data from multiple sources by an analysis of key parameters such as profit, pricing, competition, and promotions. It presents various market facets by identifying the key industry influencers. The data presented is comprehensive, reliable, and a result of extensive research - both primary and secondary. The market research reports provide a complete competitive landscape and an in-depth vendor selection methodology and analysis using qualitative and quantitative research to forecast the accurate market growth.

Product Code: IRTNTR45645

1 Executive Summary

1.1 Market overview
Exhibit 01: Executive Summary - Chart on Market Overview
Exhibit 02: Executive Summary - Data Table on Market Overview
Exhibit 03: Executive Summary - Chart on Global Market Characteristics
Exhibit 04: Executive Summary - Chart on Market By Geographical Landscape
Exhibit 05: Executive Summary - Chart on Market Segmentation by End-user
Exhibit 06: Executive Summary - Chart on Market Segmentation by Product
Exhibit 07: Executive Summary - Chart on Incremental Growth
Exhibit 08: Executive Summary - Data Table on Incremental Growth
Exhibit 09: Executive Summary - Chart on Vendor Market Positioning

2 Market Landscape

2.1 Market ecosystem
Exhibit 10: Parent market
Exhibit 11: Market Characteristics

3 Market Sizing

3.1 Market definition
Exhibit 12: Offerings of vendors included in the market definition
3.2 Market segment analysis
Exhibit 13: Market segments
3.3 Market size 2023
3.4 Market outlook: Forecast for 2023-2028
Exhibit 14: Chart on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 15: Data Table on Global - Market size and forecast 2023-2028 ($ billion)
Exhibit 16: Chart on Global Market: Year-over-year growth 2023-2028 (%)
Exhibit 17: Data Table on Global Market: Year-over-year growth 2023-2028 (%)

4 Historic Market Size

4.1 Global POC hematology diagnostics market 2018 - 2022
Exhibit 18: Historic Market Size - Data Table on global poc hematology diagnostics market 2018 - 2022 ($ billion)
4.2 End-user Segment Analysis 2018 - 2022
Exhibit 19: Historic Market Size - End-user Segment 2018 - 2022 ($ billion)
4.3 Product Segment Analysis 2018 - 2022
Exhibit 20: Historic Market Size - Product Segment 2018 - 2022 ($ billion)
4.4 Geography Segment Analysis 2018 - 2022
Exhibit 21: Historic Market Size - Geography Segment 2018 - 2022 ($ billion)
4.5 Country Segment Analysis 2018 - 2022
Exhibit 22: Historic Market Size - Country Segment 2018 - 2022 ($ billion)

5 Five Forces Analysis

5.1 Five forces summary
Exhibit 23: Five forces analysis - Comparison between 2023 and 2028
5.2 Bargaining power of buyers
Exhibit 24: Chart on Bargaining power of buyers - Impact of key factors 2023 and 2028
5.3 Bargaining power of suppliers
Exhibit 25: Bargaining power of suppliers - Impact of key factors in 2023 and 2028
5.4 Threat of new entrants
Exhibit 26: Threat of new entrants - Impact of key factors in 2023 and 2028
5.5 Threat of substitutes
Exhibit 27: Threat of substitutes - Impact of key factors in 2023 and 2028
5.6 Threat of rivalry
Exhibit 28: Threat of rivalry - Impact of key factors in 2023 and 2028
5.7 Market condition
Exhibit 29: Chart on Market condition - Five forces 2023 and 2028

6 Market Segmentation by End-user

6.1 Market segments
Exhibit 30: Chart on End-user - Market share 2023-2028 (%)
Exhibit 31: Data Table on End-user - Market share 2023-2028 (%)
6.2 Comparison by End-user
Exhibit 32: Chart on Comparison by End-user
Exhibit 33: Data Table on Comparison by End-user
6.3 Hospitals and clinics - Market size and forecast 2023-2028
Exhibit 34: Chart on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 35: Data Table on Hospitals and clinics - Market size and forecast 2023-2028 ($ billion)
Exhibit 36: Chart on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
Exhibit 37: Data Table on Hospitals and clinics - Year-over-year growth 2023-2028 (%)
6.4 Homecare settings - Market size and forecast 2023-2028
Exhibit 38: Chart on Homecare settings - Market size and forecast 2023-2028 ($ billion)
Exhibit 39: Data Table on Homecare settings - Market size and forecast 2023-2028 ($ billion)
Exhibit 40: Chart on Homecare settings - Year-over-year growth 2023-2028 (%)
Exhibit 41: Data Table on Homecare settings - Year-over-year growth 2023-2028 (%)
6.5 Clinical diagnostic laboratories - Market size and forecast 2023-2028
Exhibit 42: Chart on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibit 43: Data Table on Clinical diagnostic laboratories - Market size and forecast 2023-2028 ($ billion)
Exhibit 44: Chart on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
Exhibit 45: Data Table on Clinical diagnostic laboratories - Year-over-year growth 2023-2028 (%)
6.6 Market opportunity by End-user
Exhibit 46: Market opportunity by End-user ($ billion)
Exhibit 47: Data Table on Market opportunity by End-user ($ billion)

7 Market Segmentation by Product

7.1 Market segments
Exhibit 48: Chart on Product - Market share 2023-2028 (%)
Exhibit 49: Data Table on Product - Market share 2023-2028 (%)
7.2 Comparison by Product
Exhibit 50: Chart on Comparison by Product
Exhibit 51: Data Table on Comparison by Product
7.3 Consumables - Market size and forecast 2023-2028
Exhibit 52: Chart on Consumables - Market size and forecast 2023-2028 ($ billion)
Exhibit 53: Data Table on Consumables - Market size and forecast 2023-2028 ($ billion)
Exhibit 54: Chart on Consumables - Year-over-year growth 2023-2028 (%)
Exhibit 55: Data Table on Consumables - Year-over-year growth 2023-2028 (%)
7.4 Systems - Market size and forecast 2023-2028
Exhibit 56: Chart on Systems - Market size and forecast 2023-2028 ($ billion)
Exhibit 57: Data Table on Systems - Market size and forecast 2023-2028 ($ billion)
Exhibit 58: Chart on Systems - Year-over-year growth 2023-2028 (%)
Exhibit 59: Data Table on Systems - Year-over-year growth 2023-2028 (%)
7.5 Market opportunity by Product
Exhibit 60: Market opportunity by Product ($ billion)
Exhibit 61: Data Table on Market opportunity by Product ($ billion)

8 Customer Landscape

8.1 Customer landscape overview
Exhibit 62: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria

9 Geographic Landscape

9.1 Geographic segmentation
Exhibit 63: Chart on Market share By Geographical Landscape 2023-2028 (%)
Exhibit 64: Data Table on Market share By Geographical Landscape 2023-2028 (%)
9.2 Geographic comparison
Exhibit 65: Chart on Geographic comparison
Exhibit 66: Data Table on Geographic comparison
9.3 North America - Market size and forecast 2023-2028
Exhibit 67: Chart on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 68: Data Table on North America - Market size and forecast 2023-2028 ($ billion)
Exhibit 69: Chart on North America - Year-over-year growth 2023-2028 (%)
Exhibit 70: Data Table on North America - Year-over-year growth 2023-2028 (%)
9.4 Europe - Market size and forecast 2023-2028
Exhibit 71: Chart on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 72: Data Table on Europe - Market size and forecast 2023-2028 ($ billion)
Exhibit 73: Chart on Europe - Year-over-year growth 2023-2028 (%)
Exhibit 74: Data Table on Europe - Year-over-year growth 2023-2028 (%)
9.5 Asia - Market size and forecast 2023-2028
Exhibit 75: Chart on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 76: Data Table on Asia - Market size and forecast 2023-2028 ($ billion)
Exhibit 77: Chart on Asia - Year-over-year growth 2023-2028 (%)
Exhibit 78: Data Table on Asia - Year-over-year growth 2023-2028 (%)
9.6 Rest of World (ROW) - Market size and forecast 2023-2028
Exhibit 79: Chart on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 80: Data Table on Rest of World (ROW) - Market size and forecast 2023-2028 ($ billion)
Exhibit 81: Chart on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
Exhibit 82: Data Table on Rest of World (ROW) - Year-over-year growth 2023-2028 (%)
9.7 US - Market size and forecast 2023-2028
Exhibit 83: Chart on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 84: Data Table on US - Market size and forecast 2023-2028 ($ billion)
Exhibit 85: Chart on US - Year-over-year growth 2023-2028 (%)
Exhibit 86: Data Table on US - Year-over-year growth 2023-2028 (%)
9.8 Germany - Market size and forecast 2023-2028
Exhibit 87: Chart on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 88: Data Table on Germany - Market size and forecast 2023-2028 ($ billion)
Exhibit 89: Chart on Germany - Year-over-year growth 2023-2028 (%)
Exhibit 90: Data Table on Germany - Year-over-year growth 2023-2028 (%)
9.9 UK - Market size and forecast 2023-2028
Exhibit 91: Chart on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 92: Data Table on UK - Market size and forecast 2023-2028 ($ billion)
Exhibit 93: Chart on UK - Year-over-year growth 2023-2028 (%)
Exhibit 94: Data Table on UK - Year-over-year growth 2023-2028 (%)
9.10 China - Market size and forecast 2023-2028
Exhibit 95: Chart on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 96: Data Table on China - Market size and forecast 2023-2028 ($ billion)
Exhibit 97: Chart on China - Year-over-year growth 2023-2028 (%)
Exhibit 98: Data Table on China - Year-over-year growth 2023-2028 (%)
9.11 Canada - Market size and forecast 2023-2028
Exhibit 99: Chart on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 100: Data Table on Canada - Market size and forecast 2023-2028 ($ billion)
Exhibit 101: Chart on Canada - Year-over-year growth 2023-2028 (%)
Exhibit 102: Data Table on Canada - Year-over-year growth 2023-2028 (%)
9.12 Market opportunity By Geographical Landscape
Exhibit 103: Market opportunity By Geographical Landscape ($ billion)
Exhibit 104: Data Tables on Market opportunity By Geographical Landscape ($ billion)

10 Drivers, Challenges, and Trends

10.1 Market drivers
10.2 Market challenges
10.3 Impact of drivers and challenges
Exhibit 105: Impact of drivers and challenges in 2023 and 2028
10.4 Market trends

11 Vendor Landscape

11.1 Overview
11.2 Vendor landscape
Exhibit 106: Overview on Criticality of inputs and Factors of differentiation
11.3 Landscape disruption
Exhibit 107: Overview on factors of disruption
11.4 Industry risks
Exhibit 108: Impact of key risks on business

12 Vendor Analysis

12.1 Vendors covered
Exhibit 109: Vendors covered
12.2 Market positioning of vendors
Exhibit 110: Matrix on vendor position and classification
12.3 A. Menarini Industrie Farmaceutiche Riunite Srl
Exhibit 111: A. Menarini Industrie Farmaceutiche Riunite Srl - Overview
Exhibit 112: A. Menarini Industrie Farmaceutiche Riunite Srl - Product / Service
Exhibit 113: A. Menarini Industrie Farmaceutiche Riunite Srl - Key offerings
12.4 Abbott Laboratories
Exhibit 114: Abbott Laboratories - Overview
Exhibit 115: Abbott Laboratories - Business segments
Exhibit 116: Abbott Laboratories - Key news
Exhibit 117: Abbott Laboratories - Key offerings
Exhibit 118: Abbott Laboratories - Segment focus
12.5 Danaher Corp.
Exhibit 119: Danaher Corp. - Overview
Exhibit 120: Danaher Corp. - Business segments
Exhibit 121: Danaher Corp. - Key news
Exhibit 122: Danaher Corp. - Key offerings
Exhibit 123: Danaher Corp. - Segment focus
12.6 DIAGON Kft.
Exhibit 124: DIAGON Kft. - Overview
Exhibit 125: DIAGON Kft. - Product / Service
Exhibit 126: DIAGON Kft. - Key offerings
12.7 Diamond Diagnostics Inc.
Exhibit 127: Diamond Diagnostics Inc. - Overview
Exhibit 128: Diamond Diagnostics Inc. - Product / Service
Exhibit 129: Diamond Diagnostics Inc. - Key offerings
12.8 Drucker Diagnostics LLC
Exhibit 130: Drucker Diagnostics LLC - Overview
Exhibit 131: Drucker Diagnostics LLC - Product / Service
Exhibit 132: Drucker Diagnostics LLC - Key offerings
12.9 EKF Diagnostics Holdings Plc
Exhibit 133: EKF Diagnostics Holdings Plc - Overview
Exhibit 134: EKF Diagnostics Holdings Plc - Business segments
Exhibit 135: EKF Diagnostics Holdings Plc - Key offerings
Exhibit 136: EKF Diagnostics Holdings Plc - Segment focus
12.10 F. Hoffmann La Roche Ltd.
Exhibit 137: F. Hoffmann La Roche Ltd. - Overview
Exhibit 138: F. Hoffmann La Roche Ltd. - Business segments
Exhibit 139: F. Hoffmann La Roche Ltd. - Key news
Exhibit 140: F. Hoffmann La Roche Ltd. - Key offerings
Exhibit 141: F. Hoffmann La Roche Ltd. - Segment focus
12.11 HORIBA Ltd.
Exhibit 142: HORIBA Ltd. - Overview
Exhibit 143: HORIBA Ltd. - Business segments
Exhibit 144: HORIBA Ltd. - Key offerings
Exhibit 145: HORIBA Ltd. - Segment focus
12.12 Medsource Ozone Biomedicals Pvt. Ltd.
Exhibit 146: Medsource Ozone Biomedicals Pvt. Ltd. - Overview
Exhibit 147: Medsource Ozone Biomedicals Pvt. Ltd. - Product / Service
Exhibit 148: Medsource Ozone Biomedicals Pvt. Ltd. - Key offerings
12.13 Nova Biomedical Corp.
Exhibit 149: Nova Biomedical Corp. - Overview
Exhibit 150: Nova Biomedical Corp. - Product / Service
Exhibit 151: Nova Biomedical Corp. - Key offerings
12.14 Mindray Bio medical Electronics Co. Ltd.
Exhibit 152: Mindray Bio medical Electronics Co. Ltd. - Overview
Exhibit 153: Mindray Bio medical Electronics Co. Ltd. - Product / Service
Exhibit 154: Mindray Bio medical Electronics Co. Ltd. - Key offerings
12.15 Siemens AG
Exhibit 155: Siemens AG - Overview
Exhibit 156: Siemens AG - Business segments
Exhibit 157: Siemens AG - Key news
Exhibit 158: Siemens AG - Key offerings
Exhibit 159: Siemens AG - Segment focus
12.16 Sysmex Corp.
Exhibit 160: Sysmex Corp. - Overview
Exhibit 161: Sysmex Corp. - Business segments
Exhibit 162: Sysmex Corp. - Key offerings
Exhibit 163: Sysmex Corp. - Segment focus
12.17 Transasia Bio Medicals Ltd.
Exhibit 164: Transasia Bio Medicals Ltd. - Overview
Exhibit 165: Transasia Bio Medicals Ltd. - Product / Service
Exhibit 166: Transasia Bio Medicals Ltd. - Key offerings

13 Appendix

13.1 Scope of the report
13.2 Inclusions and exclusions checklist
Exhibit 167: Inclusions checklist
Exhibit 168: Exclusions checklist
13.3 Currency conversion rates for US$
Exhibit 169: Currency conversion rates for US$
13.4 Research methodology
Exhibit 170: Research methodology
Exhibit 171: Validation techniques employed for market sizing
Exhibit 172: Information sources
13.5 List of abbreviations
Exhibit 173: List of abbreviations